IVFDaily Topics

IVFDaily My account.

Logon

IVFDAILY needs sponsors to support its collection of links to online education material. Encourage your suppliers and societies -

IVFDaily has developed a list of topics to reflect treads of research or publications

Each topic contains links to articles (either open-access review articles or recent publicatons) or webinars MORE

POR - POSEIDON Criteria for Low Prognosis Patients

Key Points				see Q&A
259	for women demonstrating a poor ovarian response, NC treatment yields comparable pregnancy and live birth rates when compared to controlled ovarian stimulation methods.

	TextBook
	The POSEIDON stratification - moving from poor ovarian response to low prognosis
	DOI:10.5935/1518-0557.20200100 by JBRA Assisted Reproduction in 2021			[615]
	Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept
	DOI:10.1177/2633494120941480 by Frontiers in Endocrinology (Lausanne) in 2020			[614]
	Management Strategies for POSEIDON Groups 3 and 4
	DOI:10.3389/fendo.2019.00614 by Frontiers in Endocrinology (Lausanne) in 2019			[613]
	Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
	DOI:10.3389/fendo.2019.00439 by Frontiers in Endocrinology (Lausanne) in 2019			[612]
	Management of Women With an Unexpected Low Ovarian Response to Gonadotropin
	DOI:10.3389/fendo.2019.00387 by Frontiers in Endocrinology (Lausanne) in 2019			[611]
	Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification
	DOI:10.3389/fendo.2019.00281 by Frontiers in Endocrinology (Lausanne) in 2019			[610]
	Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why
	DOI:10.3389/fendo.2018.00461 by Frontiers in Endocrinology (Lausanne) in 2018			[609]

	Recent Publications
	Cumulative live birth rates among over 13,000 poor ovarian responders from 2015 to 2023: a retrospective cohort study assessing the efficacy of natural cycle and controlled ovarian stimulation
	DOI:10.1007/s10815-025-03544-z by Journal of Assisted Reproduction and Genetics in 2025			[2775]
	Effect of follicle-stimulating hormone dose on the risk of being classified as suboptimal responders according to the POSEIDON criteria
	DOI:10.1007/s10815-024-03296-2 by Journal of Assisted Reproduction and Genetics in 2024			[2159]
	Patients with low prognosis in ART: a Delphi consensus to identify potential clinical implications and measure the impact of POSEIDON criteria
	DOI:10.1186/s12958-024-01291-x by Reproductive Biology and Endocrinology in 2024			[2118]
	Live birth rate per fresh embryo transfer and cumulative live birth rate in patients with PCOS under the POSEIDON classification: a retrospective study
	DOI:10.3389/fendo.2024.1348771 by Frontiers in Endocrinology (Lausanne) in 2024			[1161]

This web site is NOT intended to provide medical advice, diagnosis or treatment. Please direct all medical inquiries to your doctor.